Private company
Farallon Capital Partners, L.P.
Hedge fund that raised $8.4 billion in 1990 (SEC Form D), active since 1989. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersSan Francisco, United States2
- Legal formLimited Partnership2
- Kind of organizationHedge fund2
- LEI3ZCAOF5KNLZVUBBTR7762
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O CSC - LAWYERS INCORPORATING SERVICE, 95833 Sacramento, United States2
- Registered withSecurities and Exchange Commission, 00011757072
Corporate structure
Farallon Capital Partners, L.P. sits at the top of its group. 47 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- Farallon Capital Partners, L.P. San Francisco, California, United States
- Agios Pharmaceuticals Stake · Cambridge, Massachusetts, United States
- AleAnna, Inc. Stake · Dallas, Texas
- Amyris Stake · Emeryville, California, United States
- Aramark Stake · Philadelphia, Pennsylvania, United States
- ARYA Sciences Acquisition Corp IV Stake · New York, New York
- ASSEMBLY BIOSCIENCES, INC. Stake · Wilmington, Delaware, United States
- Beam Therapeutics Stake · Cambridge, Massachusetts
- Berenson Acquisition Corp. I Stake · New York, New York
- Beta Bionics, Inc. Stake · Irvine, California
- Better Therapeutics, Inc. Stake · San Francisco, California
- Big Sky Growth Partners, Inc. Stake · Seattle, Washington
- BridgeBio Stake · Palo Alto
- Cazoo Stake · London, United Kingdom
- Change Healthcare Inc. Stake · Nashville, Tennessee
- CHINOOK THERAPEUTICS, INC. Stake · Berkeley, California, United States
- Chrome Holding Co. Stake · Sunnyvale, California, United States
- CLARIVATE PLC Stake · Y9
- Crinetics Pharmaceuticals Stake · San Diego, California, United States
- Disruptive Acquisition Corp I Stake · Austin, Texas
- Elevation Oncology, Inc. Stake · Boston, Massachusetts
- ENANTA PHARMACEUTICALS INC Stake · Watertown, Massachusetts
- Exelixis Stake · Alameda, California, United States
- Forest Road Acquisition Corp. II Stake · New York, New York
- Forte Biosciences, Inc. Stake · San Diego, California, United States
- Generation Bio Co. Stake · Cambridge, Massachusetts
- and 21 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (46 companies). Each entity in the chart links to its source.
Leadership
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Senior Managing Member of the General PartnerAndrew J.M. Spokes named Mar 6, 20263
- Managing Member of the General PartnerAvner P. Husen named Mar 6, 20263
- Managing Member of the General PartnerCameron Trexler Hillyer named Mar 6, 20263
- Managing Member of the General PartnerColby Trexler Clark named Mar 6, 20263
- Managing Member of the General PartnerDaniel S. Short named Mar 6, 20263
- Managing Member of the General PartnerDavid A. Posner named Mar 6, 20263
- Managing Member of the General PartnerDavid T. Kim named Mar 6, 20263
- Managing Member of the General PartnerDr. Thomas G. Roberts, Jr. named Mar 6, 20263
- Managing Member of the General PartnerEdric Trexler Saito named Mar 6, 20263
- Managing Member of the General PartnerHannah Trexler Dunn named Mar 6, 20263
- Managing Member of the General PartnerJohn R. Warren named Mar 6, 20263
- Managing Member of the General PartnerJoshua Trexler Dapice named Mar 6, 20263
- Managing Member of the General PartnerMark C. Wehrly named Mar 6, 20263
- Managing Member of the General PartnerMatthew Trexler Trentini named Mar 6, 20263
- Managing Member of the General PartnerMichael G. Linn named Mar 6, 20263
- Senior Managing Member of the General PartnerNicolas Trexler Giauque named Mar 6, 20263
- Managing Member of the General PartnerPatrick P. Luo named Mar 6, 20263
- Managing Member of the General PartnerPhilip D. Dreyfuss named Mar 6, 20263
- Managing Member of the General PartnerRichard P. Bollini named Mar 6, 20263
- Managing Member of the General PartnerVarun Trexler Gehani named Mar 6, 20263
Subsidiaries and ownership
Fund manager
Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.
Timeline
- Dec 6, 1989Founded Farallon Capital Partners, L.P. is founded2
Filings
5 filings to the SEC since October 2021: 5 private raises. The latest 5:
- Mar 6, 2026D/A EDGAR
- Mar 7, 2025D/A EDGAR
- Mar 8, 2024D/A EDGAR
- Mar 10, 2023D/A EDGAR
- Mar 11, 2022D/A EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
Farallon Capital Partners, L.P. has told the SEC it owns more than 5% of 46 companies, latest first (Schedules 13D and 13G).
- BridgeBioSCHEDULE 13G May 29, 20264
- InflaRx N.V.SCHEDULE 13G May 14, 20265
- Beta Bionics, Inc.SCHEDULE 13G/A Aug 13, 2025 to May 12, 20266
- Tyra Biosciences, Inc.SCHEDULE 13G/A Feb 20, 2026 to May 12, 20267
- GRAILSCHEDULE 13G/A Nov 13, 2025 to May 11, 20268
- Tango Therapeutics (United States)SCHEDULE 13G/A Jun 13, 2025 to May 11, 20269
- ASSEMBLY BIOSCIENCES, INC.SCHEDULE 13G/A Aug 15, 2025 to Feb 9, 202610
- Agios PharmaceuticalsSCHEDULE 13G/A Nov 9, 2023 to Feb 9, 202611
- Liquidia CorporationSCHEDULE 13G/A Jul 11, 2025 to Feb 9, 202612
- Revolution Medicines (United States)SCHEDULE 13G/A Nov 9, 2023 to Feb 9, 202613
- Protagonist Therapeutics, IncSCHEDULE 13G/A Feb 9, 2023 to Feb 6, 202614
- Beam TherapeuticsSCHEDULE 13G/A Jul 14, 2022 to Feb 5, 202615
- Crinetics PharmaceuticalsSCHEDULE 13G/A Sep 8, 2025 to Feb 5, 202616
- ENANTA PHARMACEUTICALS INCSCHEDULE 13G/A Feb 6, 2023 to Feb 5, 202617
- Lantheus Holdings, Inc.SCHEDULE 13G/A Nov 14, 2024 to Feb 5, 202618
- Minerva Neurosciences (United States)SCHEDULE 13G/A Dec 29, 2025 to Feb 5, 202619
- Savara IncSCHEDULE 13G/A Feb 1, 2024 to Feb 5, 202620
- ExelixisSCHEDULE 13D/A Mar 20, 2023 to Jan 5, 202621
- AramarkSCHEDULE 13G/A Feb 3, 2023 to Aug 12, 202522
- The New York Times CompanySCHEDULE 13G/A Jan 2, 2024 to Aug 12, 202523
- Chrome Holding Co.SCHEDULE 13G Jun 20, 202524
- Elevation Oncology, Inc.SCHEDULE 13G/A Jan 22, 2024 to May 7, 202525
- AleAnna, Inc.SCHEDULE 13G/A Feb 9, 2023 to Feb 10, 202526
- Forte Biosciences, Inc.SCHEDULE 13G/A Aug 10, 2023 to Feb 10, 202527
- Longboard Pharmaceuticals, Inc.SC 13G/A Feb 3, 2023 to Nov 8, 202428
- SquarespaceSC 13D Oct 16, 202429
- NanoString TechnologiesSC 13G May 17, 202430
- CazooSC 13D/A Mar 24, 2023 to Feb 5, 202431
- Berenson Acquisition Corp. ISC 13G/A Oct 8, 2021 to Jan 30, 202432
- Forest Road Acquisition Corp. IISC 13G/A Apr 6, 2023 to Jan 25, 202433
All 46 companies
- Tectonic Therapeutic, Inc.SC 13G/A Feb 17, 2023 to Jan 24, 202434
- Disruptive Acquisition Corp ISC 13G/A Jan 31, 2023 to Jan 19, 202435
- ARYA Sciences Acquisition Corp IVSC 13G/A Jan 31, 2023 to Jan 18, 202436
- CHINOOK THERAPEUTICS, INC.SC 13D Aug 11, 202337
- Shelter Acquisition Corp ISC 13G/A Feb 9, 202338
- AmyrisSC 13G/A Feb 7, 202339
- Better Therapeutics, Inc.SC 13G/A Nov 8, 2021 to Feb 7, 202340
- CLARIVATE PLCSC 13G/A Sep 7, 2022 to Feb 7, 202341
- SEP Acquisition Corp.SC 13G/A Feb 6, 202342
- Big Sky Growth Partners, Inc.SC 13G/A Feb 1, 202343
- Generation Bio Co.SC 13G/A Feb 1, 202344
- Imago BioSciences, Inc.SC 13G/A Feb 1, 202345
- Change Healthcare Inc.SC 13D Oct 7, 202246
- SDCL EDGE Acquisition CorpSC 13G Nov 9, 202147
- Marblegate Acquisition Corp.SC 13G Oct 12, 202148
- Intuitive MachinesSC 13G Oct 1, 202149
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $8.4B
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 1990 | $8.4B | $8.4B |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49